Ef­fi­ca­cy of Pfiz­er's Covid pill holds up in fi­nal analy­sis, re­duc­ing risk of hos­pi­tal­iza­tion or death by al­most 90%

The dras­tic dif­fer­ence in ef­fi­ca­cy for Mer­ck’s Covid-19 pill be­tween in­ter­im and fi­nal analy­ses — from a 50% rel­a­tive re­duc­tion in hos­pi­tal­iza­tions and deaths at the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER